A Comparison of Involved-Field Radiation Therapy Treatment Outcomes in Pediatric and Young Adult Hodgkin Lymphoma

被引：0
|
作者：
Huynh-Le, M. [1 ]
Walker, A. [1 ]
Wharam, M. [1 ]
Priel, I. Paz [1 ]
Terezakis, S. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.1589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S600 / S601
页数：2
相关论文
共 50 条
  • [41] A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk
    Koh, Eng-Siew
    Tran, Tu Huan
    Heydarian, Mostafa
    Sachs, Rainer K.
    Tsang, Richard W.
    Brenner, David J.
    Pintilie, Melania
    Xu, Tony
    Chung, June
    Paul, Narinder
    Hodgson, David C.
    RADIATION ONCOLOGY, 2007, 2 (1)
  • [42] Role of Radiation Therapy in the Treatment of Hodgkin Lymphoma
    Victor J. Gonzalez
    Current Hematologic Malignancy Reports, 2017, 12 : 244 - 250
  • [43] Outcomes After Involved-field Radiation Therapy (IFRT) With or Without Rituximab in Patients With Early-stage Low-grade Non-Hodgkin Lymphoma (NHL) Staged With CT and PET
    Lukens, John N.
    Nasta, Sunita D.
    Fram, Brianna
    Glatstein, Eli
    Plastaras, John P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 35 - 40
  • [44] Trends in Utilization of Radiation in the Treatment of Pediatric Hodgkin Lymphoma
    Madden, N. A.
    Marascio, J. A.
    Rabatic, B. M.
    Zaenger, D.
    McDonough, C.
    Johnson, T. S.
    Kong, F. M.
    Marchan, E. M.
    Shaaban, S.
    Martin, W.
    Dasher, B. G.
    Stewart, J. G.
    Howington, J.
    Al-Basheer, A.
    Amoush, A.
    Huang, K.
    Green, A.
    Pishgou, M.
    Ferguson, C. L.
    Mourad, W. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E553 - E553
  • [45] A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk
    Eng-Siew Koh
    Tu Huan Tran
    Mostafa Heydarian
    Rainer K Sachs
    Richard W Tsang
    David J Brenner
    Melania Pintilie
    Tony Xu
    June Chung
    Narinder Paul
    David C Hodgson
    Radiation Oncology, 2
  • [46] Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
    Hudson, MM
    Krasin, M
    Link, MP
    Donaldson, SS
    Billups, C
    Merchant, TE
    Kun, L
    Billet, AL
    Kaste, S
    Tarbell, NJ
    Howard, S
    Friedmann, AM
    Hurwitz, CA
    Young, JA
    Marcus, KC
    Rai, S
    Cowan, T
    Weinstein, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4541 - 4550
  • [47] Elderly patients with Hodgkin Lymphoma: Extended-field radiotherapy versus involved-field radiotherapy after chemotherapy
    Eich, H. T.
    Klimm, B.
    Kriz, J.
    Haverkamp, H.
    Zimmermann, C.
    Engert, A.
    Mueller, R-P
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 27 - 27
  • [48] Estimated Doses and Late Effect Risks After Involved Node, Involved Field, and Mantle Field Treatment for Pediatric Hodgkin Lymphoma
    Maraldo, M. V.
    Jorgensen, M.
    Brodin, P.
    Aznar, M. C.
    Petersen, P. M.
    Vogelius, I. R.
    Berthelsen, A. K.
    Christensen, C. B.
    Hjalgrim, L. L.
    Specht, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S599 - S600
  • [49] A Novel Multileaf Collimator-based Photon-Proton Involved-Field Technique for Treatment of Hodgkin Lymphoma of the Neck and Mediastinum
    Goldsmith, B.
    Both, S.
    Shinkle, B.
    James, P.
    Hill-Kayser, C.
    Tochner, Z.
    Plastaras, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S612 - S613
  • [50] Comparison of involved field-versus involved node-radio-therapy in Hodgkin lymphoma: a planning analysis
    Zimmermann, C.
    Hilger, T.
    Kriz, J.
    Engert, A.
    Mueller, R-P
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 26 - 27
12345